Active 2021–2024. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2024 | IGM BIOSCIENCES, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
$10,000 | |
| 2024 | STRATEGIC MARKETING INNOVATIONS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$5,000 | |
| 2024 | IGM BIOSCIENCES, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2024 | STRATEGIC MARKETING INNOVATIONS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | |
| 2024 | IGM BIOSCIENCES, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$80,000 | |
| 2024 | STRATEGIC MARKETING INNOVATIONS |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | |
| 2024 | STRATEGIC MARKETING INNOVATIONS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$15,000 | |
| 2024 | IGM BIOSCIENCES, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$110,000 | |
| 2024 | STRATEGIC MARKETING INNOVATIONS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | |
| 2023 | STRATEGIC MARKETING INNOVATIONS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$10,000 |
| Firm | Filings | Amount |
|---|---|---|
| IGM BIOSCIENCES, INC. IN-HOUSE | 14 | $1,980,000 |
| STRATEGIC MARKETING INNOVATIONS | 19 | $180,000 |
| Issue | Activities |
|---|---|
| Medical/Disease Research/Clinical Labs | 18 |
| Defense | 13 |